Barclays’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,297
Closed -$50.8K 4750
2023
Q2
$50.8K Sell
22,297
-39,972
-64% -$91.9K ﹤0.01% 3825
2023
Q1
$122K Sell
62,269
-66,459
-52% -$138K ﹤0.01% 4071
2022
Q4
$211K Sell
128,728
-139,672
-52% -$218K ﹤0.01% 3809
2022
Q3
$537K Buy
+268,400
New +$642K ﹤0.01% 2659

Other funds holding LIAN

Barclays's LIAN Position: Q3 2023 in Review

Barclays sold out of LianBio American Depositary Shares (LIAN) in Q3 2023, closing a stake of 22,297 shares — an estimated $50.8K sold.

Barclays first reported a position in LIAN in Q3 2022 and held it in 4 quarters. The position peaked at $537K in Q3 2022. 38 funds tracked by Wall St. Rank hold LIAN as of Q3 2023.

  • Barclays reported no remaining LianBio American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Barclays sold 22,297 LianBio American Depositary Shares shares in Q3 2023, an estimated $50.8K.
  • Barclays first reported a position in LianBio American Depositary Shares in Q3 2022 and held it in 4 quarters.
  • Barclays's LianBio American Depositary Shares position peaked at $537K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q3 2023.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.